Keywords: roche, begins, trial, pegasys, copegus, post-transplant, hep

Roche begins trial for Pegasys and Copegus as post-transplant hep C treatment

Article | 28 March 2005

Print This

Swiss drug major Roche has initiated a trial of Pegasys (pegylated interferon 2a) and Copegus (ribavirin) in the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in